U.S. Department of Health & Human Services
Children and COVID-19
Did You Know?
- COVID-19 vaccines are safe and effective. All children ages 5 years and older should get vaccinated against COVID-19. Currently, the Pfizer-BioNTech COVID-19 vaccine is the only vaccine authorized for children ages 5 and older.
- Children and teens ages 12 years and older receive the same dose as adults, and children ages 5-11 years receive a smaller dose.
- All children ages 5-17 need two doses of the Pfizer-BioNTech vaccine. Everyone ages 12 years and older should also get a booster shot.
- Serious reactions after COVID-19 vaccination in children and teens are rare. The benefit of increased protection against serious illness or death far outweighs the risk of serious side effects.
Event
COVID-19 Science and Your Kids: Get the Facts with BlackDoctor.org
May 19, 2022
|
8:00 - 9:00 PM ET
Featured Resources
Fact Sheet
Questions (and Answers) About Children and Teens and COVID-19 Vaccines
- Source: NIH Community Engagement Alliance (CEAL)
- File Info: PDF (2 pages)
Updated:
Also available in Spanish
Hoja informativa
Preguntas (y respuestas) sobre los niños y los adolescentes y las vacunas contra el COVID-19
- Source: NIH Community Engagement Alliance (CEAL)
- File Info: PDF (3 pages)
Updated:
Video
Ask a Doctor: Why is it important for young children to be vaccinated against COVID?
- Source: U.S. Department of Health and Human Services (HHS)
- File Info: (0:44)
Updated:
Also available in Spanish
Video
Pregúntale a un doctor: ¿Por qué es importante que los niños menores se vacunen contra el COVID?
- Source: U.S. Department of Health and Human Services (HHS)
- File Info: (0:49)
Updated:
Fact Sheet
Q & A with Dr. Jaime Deville: COVID-19 and Back to School
- Source: NIH Community Engagement Alliance (CEAL)
- File Info: Web
Updated:
Other Pediatric Resources
- COVID-19 Vaccines for Children and Teens (CDC website)
- Ensuring Vaccine Safety for Children (NIH website)
- What should I know about vaccines for children and teens | The Ad Council (getvaccineanswers.org)
- Effectiveness of BNT162b2 (Pfizer-BioNTech) mRNA Vaccination Against Multisystem Inflammatory Syndrome in Children Among Persons Aged 12–18 Years — United States, July–December 2021 (CDC website)
Featured News
Get Inspired
Image
Get Inspired
See the people who inspire our CEAL community every day -- Pediatricians, Volunteers and Researchers.
View the CEAL Pathway